NCT02440932

Brief Summary

Low-phenylalanine diets are commonly prescribed to people with phenylketonuria (PKU), an inborn disease which causes accumulation of amino acid phenylalanine (Phe) in the blood. High blood Phe levels can cause mental, behavioural, neurological, and physical problems. Thus, low-phenylalanine diets help patients to manage their condition but it is not clear whether they have an impact on appetite, energy intake and changes in body weight. This is important to explore as prevalence of obesity in this population is rising high. This study aims to find out the effect of PKU-type meals on appetite, appetite biomarkers, and post-meal energy expenditure. The investigators will recruit 26 healthy adults and ask them to participate in two experimental trials. On one occasion the participants will be asked to consume a PKU-supplemented drink followed by a PKU type-lunch and on another occasion the supplement and lunch will be based on normally consumed foods. Series of blood samples will be taken and appetite will be assessed during both experiments. Both experimental trials will finish with consuming an "all-you-can-eat" buffet.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2014

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2014

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

April 30, 2015

Completed
12 days until next milestone

First Posted

Study publicly available on registry

May 12, 2015

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2016

Completed
Last Updated

May 23, 2016

Status Verified

May 1, 2016

Enrollment Period

1.3 years

First QC Date

April 30, 2015

Last Update Submit

May 20, 2016

Conditions

Keywords

low Phenylalanine dietPKU supplementsdiet induced thermogenesisappetitebody weight

Outcome Measures

Primary Outcomes (7)

  • Appetite hormone: peptide YY (PYY)

    Plasma concentration at baseline (0 minute) and after ingestion of supplement (at 30, 60 and 90 minutes) and lunch (at 120, 150,180, 210, 240, 270 and 300 minutes)

    300 minutes

  • Appetite hormone: glucagon-like peptide-1 (GLP-1)

    Plasma concentration at baseline (0 minute) and after ingestion of supplement (at 30, 60 and 90 minutes) and lunch (at 120, 150,180, 210, 240, 270 and 300 minutes)

    300 minutes

  • Appetite hormone: cholecystokinin (CCK)

    Plasma concentration at baseline (0 minute) and after ingestion of supplement (at 30, 60 and 90 minutes) and lunch (at 120, 150,180, 210, 240, 270 and 300 minutes)

    300 minutes

  • Appetite hormone: insulin

    Plasma concentration at baseline (0 minute) and after ingestion of supplement (at 30, 60 and 90 minutes) and lunch (at 120, 150,180, 210, 240, 270 and 300 minutes)

    300 minutes

  • Appetite hormone: ghrelin

    Plasma concentration at baseline (0 minute) and after ingestion of supplement (at 30, 60 and 90 minutes) and lunch (at 120, 150,180, 210, 240, 270 and 300 minutes)

    300 minutes

  • Subjective appetite score

    Visual analogue scale (VAS) collected at baseline and after each blood sample collection

    300 minutes

  • Diet induced thermogenesis

    Metabolic rate by means of computerised open-circuit ventilated hood system collected at baseline and after each blood sample collection for the duration of 20 minutes

    300 minutes

Secondary Outcomes (2)

  • Taste perception of PKU supplements/foods

    10 minutes

  • Consumption time for PKU supplements/foods

    20 minutes

Study Arms (2)

Phenylketonuria-type diet

EXPERIMENTAL

Breakfast: one pouch of amino acid supplement (174 mls supplemented drink PKU cooler 20, Vitaflo®; 20 g protein, 9.4 g carbohydrates, 0.7 g Fat) Lunch: cheese sandwich \[low protein bread (Juvela, UK), no protein vegan cheese (Viotros, UK)\], low protein crackers (Vitaflo, UK), and low protein cookies (Juvela, UK). Dinner: ad libitum buffet meal

Dietary Supplement: Phenylketonuria-type dietOther: Normal (control) diet

Normal diet

OTHER

Breakfast: 174 ml of milk (20 g protein, 9.4 g carbohydrates, 0.7 g Fat) Lunch: cheese sandwich, crackers, and cookies (regular foods) Dinner: ad libitum buffet meal

Dietary Supplement: Phenylketonuria-type dietOther: Normal (control) diet

Interventions

Phenylketonuria-type dietDIETARY_SUPPLEMENT

Breakfast, lunch and open buffet dinner

Normal dietPhenylketonuria-type diet

Breakfast, lunch and open buffet dinner

Normal dietPhenylketonuria-type diet

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy adult
  • Body weight stable for previous 4 months
  • Regular menstrual cycle (females)

You may not qualify if:

  • Pregnancy or lactation (females)
  • History of eating disorder
  • History of gastrointestinal problems or surgery
  • History of allergy
  • History of chronic illness
  • On any medication
  • Smoking
  • On nutritional supplements
  • Following specific diet
  • Currently taking part in other research

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Human Nutrition, School of Medicine, University of Glasgow

Glasgow, G31 2ER, United Kingdom

Location

Related Publications (1)

  • Alfheeaid H, Gerasimidis K, Nastase AM, Elhauge M, Cochrane B, Malkova D. Impact of phenylketonuria type meal on appetite, thermic effect of feeding and postprandial fat oxidation. Clin Nutr. 2018 Jun;37(3):851-857. doi: 10.1016/j.clnu.2017.03.005. Epub 2017 Mar 8.

MeSH Terms

Conditions

PhenylketonuriasBody Weight

Interventions

Diet

Condition Hierarchy (Ancestors)

Brain Diseases, Metabolic, InbornBrain Diseases, MetabolicBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesAmino Acid Metabolism, Inborn ErrorsMetabolism, Inborn ErrorsGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesMetabolic DiseasesNutritional and Metabolic DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Nutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • Dalia Malkova, PhD

    University of Glasgow

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Lecturer

Study Record Dates

First Submitted

April 30, 2015

First Posted

May 12, 2015

Study Start

November 1, 2014

Primary Completion

March 1, 2016

Study Completion

March 1, 2016

Last Updated

May 23, 2016

Record last verified: 2016-05

Locations